+ Watch ASTX.DL
on My Watchlist
A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.
On 30 stocks over $50 million market cap magic formula screen.5* CAPS rated small pharmaceutical company. Schwab rates it a B. They make drugs to cure / treat cancer. They do have a nice amount of cash with no debt. And it appears that most of the stock price is cash / book value of the company, as it has been for several years now. It doesn’t seem that any of there past products are huge and all of their current products are still in the development stages, so there are not much hope of good news soon. I just don’t seem them making any money from operations for the next several years. If they can’t find some more revenue, they might have to scale back and sell some assets, at which point the stock price will drop. Not much here to really want to invest in. Moving on.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions